Cambridge Investment Research Advisors, Inc. First Tr ETF Vi Nasdaq Pharmac Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.9 Billion
  • Q4 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in First Tr ETF Vi Nasdaq Pharmac stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 13,904 shares of FTXH stock, worth $389,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,904
Holding current value
$389,312
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$26.74 - $29.16 $371,792 - $405,440
13,904 New
13,904 $375,000
Q2 2023

Jul 13, 2023
SELL
$25.44 - $27.16 $207,361 - $221,381
-8,151 Reduced 34.36%
15,572 $408,000
Q1 2023

May 11, 2023
BUY
$25.25 - $28.3 $146,652 - $164,366
5,808 Added 32.42%
23,723 $619,000
Q4 2022

Feb 08, 2023
BUY
$24.01 - $28.45 $430,139 - $509,681
17,915 New
17,915 $491,000

Others Institutions Holding FTXH

# of Institutions
23
Shares Held
214K
Call Options Held
0
Put Options Held
0
View Full List

About FIRST TR ETF VI NASDAQ PHARMAC

FTXH Quotes by TradingView
  • Ticker FTXH
  • Sector ETFs
  • Industry ETFs
More about FTXH
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email